HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nadège Corradini Selected Research

MB 5

1/2018Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nadège Corradini Research Topics

Disease

29Neoplasms (Cancer)
10/2022 - 09/2009
14Sarcoma (Soft Tissue Sarcoma)
10/2022 - 11/2009
11Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 11/2009
8Rhabdomyosarcoma
08/2021 - 11/2009
6Ewing Sarcoma (Sarcoma, Ewing)
08/2022 - 11/2009
6Neoplasm Metastasis (Metastasis)
01/2020 - 10/2010
2Central Nervous System Neoplasms
10/2022 - 01/2020
2Disease Progression
01/2021 - 01/2020
2Medulloblastoma
01/2020 - 01/2018
2Dysgerminoma
01/2018 - 02/2011
2Brain Neoplasms (Brain Tumor)
01/2018 - 07/2012
2Neuroblastoma
01/2018 - 11/2016
2Bone Resorption
01/2016 - 10/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022
1Aggressive Fibromatosis (Desmoid)
01/2021
1Fibroma (Fibromatosis)
01/2021
1Hypoxia (Hypoxemia)
10/2020
1Paraganglioma (Paragangliomas)
05/2020
1Malignant mesenchymal tumor
01/2020
1Giant Cell Tumors (Giant Cell Tumor)
01/2020
1Hodgkin Disease (Hodgkin's Disease)
01/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020
1Second Primary Neoplasms (Neoplasms, Second)
01/2020
1Primitive Neuroectodermal Tumors (PNET)
01/2020
1Ototoxicity
07/2018
1Mesothelioma
04/2018
1Glioma (Gliomas)
01/2018
1Ependymoma
01/2018
1Cardiomyopathies (Cardiomyopathy)
08/2016
1Rectal Diseases (Rectal Disease)
05/2015
1Rectal Neoplasms (Rectal Cancer)
05/2015
1Pathologic Complete Response
05/2015
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
02/2014
1Child Nutrition Disorders
11/2012
1Weight Loss (Weight Reduction)
11/2012
1Malnutrition (Nutritional Deficiencies)
11/2012

Drug/Important Bio-Agent (IBA)

4RNA (Ribonucleic Acid)IBA
10/2022 - 07/2015
4Etoposide (VP 16)FDA LinkGeneric
01/2022 - 03/2011
4Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 01/2018
4Zoledronic Acid (Zometa)FDA Link
08/2016 - 10/2010
3Tyrosine Kinase InhibitorsIBA
10/2022 - 01/2020
3IfosfamideFDA LinkGeneric
01/2022 - 01/2018
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 10/2012
3Sirolimus (Rapamycin)FDA Link
11/2021 - 11/2015
3Topotecan (Hycamtin)FDA LinkGeneric
11/2021 - 10/2010
3Temozolomide (Temodar)FDA LinkGeneric
11/2021 - 10/2010
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2020
2NucleotidesIBA
01/2022 - 01/2018
2Irinotecan (Camptosar)FDA LinkGeneric
10/2020 - 07/2012
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 07/2018
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
01/2020 - 12/2019
2Vinorelbine (Navelbine)FDA LinkGeneric
12/2019 - 10/2012
2PlatinumIBA
07/2018 - 01/2018
2Carboplatin (JM8)FDA LinkGeneric
07/2018 - 03/2011
2Cell-Free Nucleic AcidsIBA
01/2018 - 11/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2017 - 07/2012
2Diphosphonates (Bisphosphonates)IBA
10/2011 - 10/2010
1entrectinibIBA
10/2022
1ParaffinIBA
01/2022
1Formaldehyde (Formol)FDA Link
01/2022
1Vincristine (Oncovin)FDA LinkGeneric
01/2022
1vistusertibIBA
11/2021
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2021
1Mechanistic Target of Rapamycin Complex 1IBA
11/2021
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2021
1Succinate Dehydrogenase (Fumarate Reductase)IBA
05/2020
1AntibodiesIBA
01/2020
1CI 22IBA
01/2020
1atezolizumabIBA
01/2020
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2020
1Oncogene Proteins (Oncogene Protein)IBA
01/2020
1penicillamine-glutathione mixed disulfideIBA
01/2019
1MB 5IBA
01/2018
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
06/2017
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2017
1DNA (Deoxyribonucleic Acid)IBA
11/2016
1Ethanolamine (Colamine)IBA
01/2016
1mifamurtideIBA
01/2016
1Biological ProductsIBA
01/2016
1EWS-FLI fusion proteinIBA
07/2015
1Monoclonal AntibodiesIBA
07/2012
1Bevacizumab (Avastin)FDA Link
07/2012

Therapy/Procedure

17Drug Therapy (Chemotherapy)
08/2022 - 08/2010
13Therapeutics
08/2021 - 08/2010
5Radiotherapy
08/2021 - 06/2013
2Aftercare (After-Treatment)
07/2017 - 11/2009
1Duration of Therapy
10/2022
1Induction Chemotherapy
01/2021
1Autologous Transplantation
01/2020
1Hyperthermic Intraperitoneal Chemotherapy
04/2018
1Cytoreduction Surgical Procedures
04/2018
1Intravenous Infusions
08/2016
1Off-Label Use
11/2015
1Brachytherapy
05/2015
1Conservative Treatment
05/2015
1Salvage Therapy
02/2014
1Enteral Nutrition (Feeding, Tube)
11/2012
1Gastrostomy
11/2012